Treating autoimmune diseases through restoration of antigen-specific immune tolerance

Archivum Immunologiae Et Therapiae Experimentalis
Lawrence A Wolfraim

Abstract

The first line of treatment for many human autoimmune diseases involves the use of anti-inflammatory or immunosuppressive drugs such as prednisone or other steroids that not only suppress the underlying autoimmune disease, but lead to global suppression of the immune system. The sequelae of this approach include increased risk of infection, carcinogenesis, and osteoporosis. Moreover, such broad spectrum immunosuppression tends to have transient therapeutic benefit, as in many cases the disease becomes refractory to these drugs. There is a clear need for more specific means to restore immune tolerance to the specific autoantigens implicated in disease pathology. This review provides an overview of some of these newer, more specific therapeutic approaches to restoring immune tolerance to autoantigens, with an emphasis on those approaches that have been or will soon be tested in controlled clinical trials. Covered here are peptide- or protein-based therapeutics, oral tolerance, and cellular and gene therapy approaches to restoring antigen-specific immune tolerance.

Citations

Jan 14, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Miguel G ToscanoDoina Ganea
Aug 27, 2009·Biologics : Targets & Therapy·Mary H Foster
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Dan PeerMotomu Shimaoka
Feb 14, 2007·Archives of Dermatological Research·Ana Paula Pereira VelosaNatalino Hajime Yoshinari
Jul 18, 2012·Scientific Reports·Jezrom B FordhamLindsay B Nicholson
Apr 13, 2011·Plant Biotechnology Journal·Francesca MorandiniMario Pezzotti
Jul 17, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Sabine Hombach-KlonischMarek Los
Nov 13, 2008·Critical Reviews in Clinical Laboratory Sciences·Frederick D Coffman
Aug 3, 2010·Expert Review of Vaccines·Linda AvesaniMario Pezzotti
Feb 21, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ruby KochappanChristopher J H Porter

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Bratislavské lekárske listy
R GardlikM Bernadic
American Journal of Physiology. Gastrointestinal and Liver Physiology
Jeffrey W Card, Bernadene A Magnuson
Mini Reviews in Medicinal Chemistry
Sanjukta ChakrabartiJagat R Kanwar
© 2022 Meta ULC. All rights reserved